|
gptkb:Boehringer_Ingelheim
|
ensures drug safety through rigorous testing.
|
|
gptkb:Atea_Pharmaceuticals
|
adverse event monitoring
|
|
gptkb:Loxo_Oncology
|
clinical assessments
|
|
gptkb:Vanda_Pharmaceuticals_Ltd.
|
prioritized in all developments
|
|
gptkb:Neos_Therapeutics
|
ensures drug safety and efficacy
|
|
gptkb:Daiichi_Sankyo
|
monitoring programs
|
|
gptkb:Hengrui_Medicine
|
prioritizes drug safety
|
|
gptkb:Clovis_Oncology
|
clinical safety assessments
|
|
gptkb:Tetra_Logic_Pharmaceuticals
|
focuses on drug safety
|
|
gptkb:Shionogi_Inc.
|
Prioritizes drug safety in development
|
|
gptkb:GTx,_Inc.
|
monitored post-approval
|
|
gptkb:Eli_Lilly
|
prioritizes drug safety
|